The name behind the ingredient
A copper-peptide serum and a vial labeled GHK-Cu may share a compound name, but they don't come with the same evidence. GHK-Cu is a copper complex of glycyl-histidyl-lysine, a three-amino-acid peptide. To make sense of a skin claim, start with the form of the product and the way it was studied. Was it applied to skin? Was it part of a complete skin-care regimen? Those details are more useful than the ingredient name alone.
A small trial with a useful lesson
A randomized study published in 2006 examined skin-care regimens with and without GHK-Cu after carbon-dioxide laser resurfacing. Thirteen people completed it. The researchers did not find significant differences in objective assessments of redness resolution, wrinkles or overall skin quality. However, a patient questionnaire favored the GHK-Cu regimen on perceived improvement in skin quality. That is a more nuanced result than either a blanket endorsement or a claim that the ingredient can do nothing. Read the original study abstract.
Different outcomes answer different questions
A person’s satisfaction is meaningful, but it is not the same measure as a blinded evaluation of wrinkles. Reporting both helps readers understand the result without selecting only the favorable endpoint. The study was also small and concerned recently resurfaced skin. Applying its findings to every everyday serum, skin type or cosmetic goal would extend the evidence beyond the question the researchers tested.
A laboratory pathway is only part of the story
It is common to encounter ingredient descriptions centered on cell signaling or collagen. A proposed mechanism can explain why a substance is interesting to researchers. It does not establish the size of a visible effect from a finished product. A reader evaluating a serum should ask whether evidence concerns that formulation, an ingredient in isolation, or a different experimental setting. Those are distinct levels of support, even when the scientific vocabulary sounds similar.
What this means when reading a serum claim
Think about the question a shopper is likely to ask: will this particular serum make a visible difference to my skin? A study of a regimen after laser resurfacing doesn't directly answer that everyday-use question. Nor does a favorable satisfaction questionnaire mean that every objective measure improved. A fair reading leaves both findings in view. The useful next evidence would match the actual formulation, the setting in which it is used and the outcome being promised.
Why topical and injectable claims must stay separate
The FDA’s discussion of GHK-Cu specifically identifies concerns for injectable routes, including immune reactions and peptide-related impurities, with limited human safety data. It should not be reworded as a finding about all topical cosmetics; equally, cosmetic use does not establish injectable safety. See the FDA’s route-specific assessment. The most useful reading habit is to match every claim to the product and route actually studied. For a wider introduction to the category, read what peptides are. If a headline leaves out the route entirely, that missing detail is a reason to investigate further.
Sources & further reading
Research context last reviewed September 21, 2026. Wording, presentation and catalog links updated September 27, 2026. This article is AI-assisted and has not been reviewed by a clinician. It is educational and does not replace individual medical advice. Read our editorial approach.
